May 18, 2023 / 03:00PM GMT
Ben Shamsian - Lytham Partners, LLC - Analyst
Hello, everyone, and welcome to the Lytham Partners Spring 2023 Investor Conference. My name is Ben Shamsian, Vice President of Lytham Partners. Thank you for joining us today for our oncology panel titled, advancements in the fight against cancer.
We are joined today by two executives from two great companies from the industry to get some insights on how they see this space. I've gathered some topics of interest to investors and hope to learn greatly from our panelists.
Joining us today are Gerard Michel, CEO of Delcath Technologies (sic - Delcath Systems), ticker DCTH on the Nasdaq; as well as Dr. Anatoly Dritschilo, CEO of Shuttle Pharmaceuticals, ticker SHPH. I want to remind everyone that our management teams are available for one-on-one meetings. (Operator Instructions)
Before we begin with the discussion, I would like to have each of you introduce yourselves and provide a five-minute background on your companies. Gerard, we can start with you.
Gerard Michel - Delcath Systems, Inc. - CEO
Delcath Systems Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot